Free Shipping on purchases over €100

Obire Colágeno Hidrolizado , 30 unidades

Obire Hydrolysed Collagen , 30 units

Obire Colágeno Hidrolizado is a food supplement containing hydrolysed collagen in capsule format. Each pack contains 30 units and is recommended for the care and preservation of bones, cartilage, nails, skin and hair.

SKU: NA8435041341737
-8%
20.60
€22.32

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Collagen is an essential protein found in the human body and is responsible for the elasticity and firmness of skin, hair, nails, bones and cartilage. Over time, the body's natural production of collagen decreases and can lead to health and cosmetic complications.

Obire Hydrolysed Collagen is a supplement that helps replenish collagen levels in the body, promoting healthy skin, nails, hair and joints. It can also improve bone density and strengthen the immune system.

Hydrolysed collagen is a form of collagen that has been processed to be more easily absorbed by the body. Some of the benefits and properties of Obire Hydrolysed Collagen are:

  • Improves skin health: Collagen is essential for maintaining skin elasticity and firmness. Its regular intake prevents the appearance of wrinkles and expression lines, as well as improving skin hydration and texture.
  • It strengthens nails and hair: Collagen is an important component of nails and hair, as it strengthens them and improves their appearance.
  • Promotes healthy joints: It is a fundamental component of cartilage, which is the tissue that cushions joints. Intake of this product improves flexibility and relieves joint pain.
  • Improves bone density: Collagen is also an important building block for bones.
Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.